233 related articles for article (PubMed ID: 28721975)
1. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis.
Li Z; Wu C; Li L; Wang Z; Xie H; He X; Feng J
Saudi J Gastroenterol; 2017; 23(4):222-228. PubMed ID: 28721975
[TBL] [Abstract][Full Text] [Related]
2. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
3. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.
Kiso M; Ito M; Boda T; Kotachi T; Masuda K; Hata K; Sasaki A; Kawamura T; Yoshihara M; Tanaka S; Chayama K
Scand J Gastroenterol; 2017 Aug; 52(8):828-832. PubMed ID: 28485638
[TBL] [Abstract][Full Text] [Related]
5. The effect of proton pump inhibitors on the gastric mucosal microenvironment.
Peng YC; Huang LR; Ho HC; Chang CS; Lee SW; Cheng CC; Wen MC; Yeh HZ; Ho SP
Adv Clin Exp Med; 2017; 26(1):39-43. PubMed ID: 28397430
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis.
Dilaghi E; Bellisario M; Esposito G; Carabotti M; Annibale B; Lahner E
Front Immunol; 2022; 13():910077. PubMed ID: 35935934
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
[TBL] [Abstract][Full Text] [Related]
8. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
11. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
[TBL] [Abstract][Full Text] [Related]
13. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
14. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy.
Negovan A; Iancu M; Moldovan V; Sàrkàny K; Bataga S; Mocan S; Țilea I; Banescu C
Eur J Intern Med; 2017 Oct; 44():62-66. PubMed ID: 28576397
[TBL] [Abstract][Full Text] [Related]
15. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.
Kono Y; Okada H; Takenaka R; Miura K; Kanzaki H; Hori K; Kita M; Tsuzuki T; Kawano S; Kawahara Y; Yamamoto K
Gut Liver; 2016 Jan; 10(1):69-75. PubMed ID: 26087789
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
Kuipers EJ; Klinkenberg-Knol EC; Meuwissen SG
Yale J Biol Med; 1999; 72(2-3):211-8. PubMed ID: 10780583
[TBL] [Abstract][Full Text] [Related]
17. Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.
Miyamoto S; Kato M; Tsuda M; Matsuda K; Muranaka T; Abiko S; Ono M; Mizushima T; Omori S; Yamamoto K; Mabe K; Ono S; Kudo T; Shimizu Y; Sakamoto N
Dig Endosc; 2017 May; 29(3):307-313. PubMed ID: 27859804
[TBL] [Abstract][Full Text] [Related]
18. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety concerns with proton pump inhibitors.
Ali T; Roberts DN; Tierney WM
Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
[TBL] [Abstract][Full Text] [Related]
20. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
Kodama M; Murakami K; Okimoto T; Abe H; Sato R; Ogawa R; Mizukami K; Shiota S; Nakagawa Y; Soma W; Arita T; Fujioka T
Scand J Gastroenterol; 2013 Nov; 48(11):1249-56. PubMed ID: 24079881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
